1-3 of 3
Anna Falanga
Close
Sort by
Journal Articles

Platelet proteome reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms

Sarah Kelliher, Sara Gamba, Luisa Weiss, Zhu Shen, Marina Marchetti, Francesca Schieppati, Caitriona Scaife, Stephen Madden, Kathleen Bennett, Anne Frances Fortune, Su Wai Maung, Dr, Michael Fay, Fionnuala B Ní Áinle, Patricia B Maguire, Anna Falanga, Barry Kevane, Anandi Krishnan
Journal: Blood Advances
Blood Adv bloodadvances.2023012016.
https://doi.org/10.1182/bloodadvances.2023012016
Published: 2024
Includes: Supplemental data
Journal Articles

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

Clinical Trials & Observations
Gualtiero Palareti, Daniela Poli, Walter Ageno, Cristina Legnani, Emilia Antonucci, Eugenio Bucherini, Sophie Testa, Oriana Paoletti, Antonio Chistolini, Alessandra Serrao, Ida Martinelli, Paolo Bucciarelli, Anna Falanga, Alberto Tosetto, Luca Sarti, Daniela Mastroiacovo, Benilde Cosmi, Adriana Visonà, Rita Carlotta Santoro, Nello Zanatta, Elvira Grandone, Lorenza Bertù, Vittorio Pengo, Lucia Caiano, Paolo Prandoni
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6005–6015.
https://doi.org/10.1182/bloodadvances.2022007973
Published: 2022
Includes: Supplemental data
Journal Articles

Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans

Dmitri V. Gnatenko, Zhaoyan Liu, Patrick Hearing, Sook-Young Sohn, Yetao Hu, Anna Falanga, Song Wu, Lisa E. Malone, Wei Zhu, Wadie F. Bahou
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4884–4900.
https://doi.org/10.1182/bloodadvances.2021005648
Published: 2022
Includes: Supplemental data